| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| EDEN Bioscience Corporation |
| 11816 North Creek Parkway North, Bothell, WA 98011 * (425) 806-7300 |
| Business Description | The Company is a plant technology company focused on developing, manufacturing and marketing innovative natural products for agriculture. |
| Offering Information Company has | |||
| Trading As | EDEN (NASNTL) | Industry | Manufacturing (SIC 2879) |
| Type of Stock Offered | Common Shares | Filing Date | 7/7/00 |
| Domestic Shares Offered | 5,800,000 | Offer Date | 9/26/00 |
| Foreign Shares Offered | 0 | Filing Range | $12.00 - $14.00 |
| Company Shares | 5,800,000 | Offer Price | $15.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $1.050 |
| Gross Proceeds | $87,000,000 | Selling | $0.630 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 22,732,707 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Merrill Lynch & Co. | Lead Manager | (212) 449-4600 |
| George K. Baum & Company | Co-manager | (816) 283-5332 |
| Ragen MacKenzie Incorporated | Co-manager | (206) 343-5000 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 3 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/95 | 12/31/96 | 12/31/97 | 12/31/98 | 12/31/99 | 3/31/99 | 3/31/00 |
| Revenues | 0.242 | 0.220 | 0.183 | 0.121 | 0.115 | 0.015 | 0.000 |
| Income from Oper. | -1.017 | -1.819 | -3.255 | -6.909 | -9.649 | -2.113 | -3.180 |
| Net Income | -1.000 | -1.747 | -3.203 | -6.936 | -9.395 | -2.017 | -3.058 |
| E.P.S | -0.570 | -1.040 | -1.900 | -3.930 | -5.230 | -1.110 | -1.110 |
| Revenue Growth (%) | -9.09 | -16.82 | -33.88 | -4.959 | -100.00 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -7.84 | -1.74 | -3.18 | ||||
| Cash Flow - Inv. | -2.21 | -0.63 | -0.40 | ||||
| Cash Flow - Fin. | 11.43 | 1.59 | 0.04 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 3/31/00 | Financial Ratios | ||||
| Total Assets | 13.20 | Current Assets | 9.68 | Current Ratio | 4.71 |
| Total Liab. | 2.51 | Current Liab. | 2.06 | Debt Ratio | 19.03% |
| Total Equity | 10.69 | Working Cap. | 7.63 | Debt to Equity Ratio | 0.23 |
| Cash | 9.56 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to expand and enhance our manufacturing and research and development facilities, and the remainder for working capital and general corporate purposes, including expansion of sales and marketing capabilities for the commercialization of Messenger and for research and development activities. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Perkins Coie |
| Bank's Law Firm | Brown & Wood |
| Registrar/Transfer Agent | ChaseMellon Shareholder Services, L.L.C. |
| Auditor | Arthur Andersen |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Industry Competition |
The crop protection and treatment industry is highly competitive and is dominated by multinational chemical and pharmaceutical companies, including Novartis AG and AstraZeneca PLC (which plan to combine their agribusinesses as a new company, to be called Syngenta), Aventis S.A., Monsanto Company, BASF AG, Bayer AG, E.I. DuPont de Nemours and Company and The Dow Chemical Company. Many of these companies have substantially greater financial, technical, distribution and marketing resources than the Company does. Competition is based primarily on price and efficacy, which is generally measured by crop yield and overall cost of use to the grower. In addition, attracting and retaining qualified personnel, developing production and marketing expertise, developing proprietary products or processes and obtaining regulatory approvals on a timely basis are essential to establishing a competitive market position. |
| Business Plan |
The Company is focusing on the following key initiatives: (i) commercialize Messenger and future products based on our proprietary technology; (ii) promote the benefits of Messenger and our harpin and harpin-related technologies; (iii) continue to develop Messenger product extensions and new products that utilize natural plant defense and growth systems; (iv) control and protect our technology; and maintain control over product manufacturing. |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Britannia Holdings Limited | 14.70 | |
| Stephens Group, Inc. | 14.40 | |
| Note: represents ownership of 5% or more prior to the offering. | ||